Clinical trial
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
NCT07014293 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 3, 2026
- Completion date
- July 1, 2030
- Enrollment
- 254 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.